Thermo Fisher Scientific stock gains on higher Q2 guidance
Published on 09/19/2026 at 11:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific Inc. (ISIN US8835561023) stock closed at USD 658.32 on September 17, 2026, after a second-quarter report that showed USD 11.99 billion in revenue and adjusted EPS of USD 6.03.
Q2 numbers still set the tone
According to MarketBeat on September 19, 2026, those Q2 figures beat expectations: revenue topped the Street by USD 280 million, while adjusted EPS beat by USD 0.32. The same report said revenue rose 10.5 percent year over year and that Thermo Fisher Scientific set FY 2026 guidance at USD 24.93 to USD 25.33 in adjusted EPS.
UBS lifts its target
According to Yahoo Finance on September 18, 2026, UBS raised its price target to USD 730 from USD 540 and moved the rating to Buy from Neutral. The same article linked the call to 5 percent to 6 percent organic growth and 50 to 70 basis points of margin expansion, while Deutsche Bank pointed to funding uncertainty in the same coverage.
Stock near its high
Thermo Fisher Scientific stock traded between USD 649.00 and USD 663.57 on September 17, 2026, with a 52-week range of USD 435.27 to USD 663.57 and market capitalization of USD 243.41 billion, according to Morningstar. Volume was 874 shares in that delayed snapshot, while the stock's latest quoted price of USD 658.32 sat just below the 52-week high.
Thermo Fisher Scientific stock data
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Trading venue: NYSE
- Price (as of September 17, 2026): USD 658.32
- Market capitalization: USD 243.41 billion (as of September 17, 2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: S&P 500
